Collecting data on genomic medicine implementation in European healthcare systems for mapping and sharing successful practices.
We invite you to participate in a European survey to document the organisational frameworks put in place for the implementation of genomic medicine in national healthcare systems. This survey was developed as part of the activities of the Beyond 1 Million Genomes Plus project (B1MGplus), funded by the European Commission under the Digital Europe Programme. B1MGplus provides coordination and support to the 1+ Million Genomes initiative (1+MG), which is the commitment of 25 EU countries plus Norway to enable secure access to genomic and corresponding clinical data across Europe, supporting research, health policy and personalised healthcare.
What is the main purpose of this survey?
Citizens and patients can nowadays widely benefit from genomic data analysis for accurate and timely diagnosis, more effective treatments with fewer adverse events and, in the near future, accurate profiling for disease prevention. Nevertheless, implementation of genomics in healthcare is complex and requires adjustments in the governance, structure and organisation of health services, as well as dedicated investments. Genomic medicine implementation varies across European countries, and solutions for specific challenges have been previously developed, which can serve as best practices for other countries. This survey is a mapping exercise to document the implementation of genomic medicine in national or regional healthcare systems, facilitating sharing of experiences across countries and informing policy makers.
Therefore, this questionnaire concerns the provision of genetic and/or genomic testing in clinical setting, both for diagnosis, treatment and prevention.
Who are the respondents of this survey ?
The survey is sent to 1+MG National Mirror Groups (NMGs), with a collective answer expected per country.
What will be the outcomes of the survey?
The goal is to facilitate sharing of experiences across countries, learn from each other and provide valuable insights to policy makers, with the aim of identifying and disseminating good practices that can help reduce disparities in healthcare implementation of genomic medicine across Europe.
During the last quarter of 2026, a webinar will be organised to present to stakeholders the aggregated results and analysis of this mapping exercise. A synthesis of the results, with good practice identifications and gaps analysis will contribute to recommendations for Genome EDIC on implementation and sustainability of genomic medicine in healthcare systems.
What does participation involve?
Responses will be analysed by the B1MGplus project team at the National Institute of Health and Medical Research (Inserm), France. For the follow-up of the survey, we will ask you to provide us with a contact person. Contact details will not be published but may be made available to other experts within the 1+MG initiative and B1MGplus project.
How was the survey developed?
The survey was developed based on the insights of the 1+MG working group on Health implementation (WG7), composed of experts from 17 participating countries.
This questionnaire follows the structure of the Maturity Level model for Genomics in Healthcare developed in the context of 1+MG (https://framework.onemilliongenomes.eu/genomics-into-healthcare#maturity-level-model), with 8 domains :
- Governance and Strategy
- Investment and economic models
- Ethics, legislation and policy
- Public awareness and acceptance
- Workforce skills and organization
- Clinical organisation, infrastructure and tools
- Clinical genomics guidelines and infrastructure
- Data management, standards and infrastructure
8 clinical applications of genomic medicine have been identified :
- Rare diseases
- Prenatal genetic diagnosis
- Cancers
- Cancer genetic predisposition
- Prenatal genetic screening
- Genomic newborn screening
- Pharmacogenetics
- Complex diseases
Documents to help complete the survey
- Survey completion guide: Link
- List of questions and sub-questions to collect informations from different sources: Link
-
Slides presented on December 11, 2026 to the 1+MG representatives in NMG: Link
Questionnaire completion deadline
We kindly ask you to complete this questionnaire before March 18, 2026.
Contact for Further Information
If you have any questions please contact : survey.b1mgplus@inserm.fr
Fields marked with * are mandatory.
Thank you for your cooperation!